Price

Daily adjusted close · last point is delayed last sale · drag the brush to zoom

1D+0.3%
1W-1.3%
1M-10.5%
3M+8.6%
6M-4.7%
YTD-26.3%
1Y-27.0%
2Y-1.1%
Statusinvestigate
Researchprimary verified
Market cap$91.74B
Updated8/15/2026
Revenue (qtr)$7.50B
FCF (qtr)$-118.0M
Capex (qtr)$1.25B
Net debt$18.78B

Summary

Research status: Primary-source verified through Q2 2026. Valuation basis: $282.50 closing price on 14 August 2026.

Constellation combines the largest U.S. nuclear operating platform with the broader gas, geothermal and retail portfolio acquired through Calpine. Q2 adjusted operating EPS rose to $2.55, management raised 2026 adjusted EPS guidance to $11.50–12.50, Crane cleared important FERC and NRC milestones, and an additional 920 MW of 15–20-year nuclear PPAs was signed. This is a high-quality power-scarcity beneficiary, but not a clean diversifier from PowerFund's AI-capex thesis: large-load contracting and power prices are part of the same causal chain. At roughly 23.5x midpoint 2026 adjusted EPS, a starter position is defensible only with integration, leverage and nuclear-operation discipline.

Primary sources verified through 15 August 2026:

All 24/60-month scenario assumptions, probabilities and implied values are PowerFund calculations, not company guidance or analyst consensus.

Thesis

Investment case

Constellation owns a difficult-to-replicate fleet of nuclear plants and, following Calpine, a large portfolio of dispatchable gas generation, geothermal assets and customer-facing retail operations. Existing nuclear sites have scarce interconnections, permits, trained workforces and long useful lives. Rising electricity demand, retirements of older generation and the need for 24/7 reliable power increase the value of these assets.

The variant perception is that long-term corporate PPAs, nuclear life extensions, Crane's restart and Calpine synergies can convert volatile merchant exposure into durable per-share cash growth. The opposing case is that the acquisition increases leverage and operational complexity while regulators and politicians may limit the monetization of power scarcity. Nuclear outages, project delays and commodity hedging can create large deviations between thesis and reported GAAP earnings.

Verified operating baseline

  • Q2 2026 GAAP net income attributable to common shareholders: $513M, or $1.42 per share.
  • Q2 adjusted operating earnings: $920M, or $2.55 per share, versus $1.91 a year earlier.
  • Q2 operating revenue: $7.50B; first-half operating revenue: $18.63B, reflecting the Calpine combination.
  • 2026 adjusted operating EPS guidance increased to $11.50–12.50.
  • Nuclear output in Q2 was 44,160 GWh; owned nuclear capacity factor excluding Salem and South Texas Project was 93.0%, versus 94.8% a year earlier.
  • The gas, oil and pumped-storage fleet's Q2 equivalent forced-outage factor was 6.2%.
  • FERC approved transfer of capacity interconnection rights to Crane, and the NRC approved a fuel-license amendment supporting the planned 2027 restart.
  • Constellation signed an additional 920 MW of nuclear PPAs lasting 15–20 years with investment-grade customers.
  • The company agreed to sell Brazos Valley Energy Center for $860M, completing a required Calpine-related divestiture step.

Valuation scenarios

PowerFund scenarios based on $282.50 on 14 August 2026. EPS is adjusted/normalized; dividends are excluded.

24 months

CaseWeightCore assumptionsImplied valueReturn / CAGR
Bear25%$11 EPS; 18x P/E; integration, outages and regulation offset stronger power markets$198-29.9% / -16.3%
Base50%$15 EPS; 24x P/E; Calpine synergies and contracted nuclear growth progress$360+27.4% / +12.9%
Bull25%$20 EPS; 28x P/E; Crane, PPAs and market pricing exceed expectations$560+98.2% / +40.8%

Probability-weighted working value: approximately $370, or 14.4% annualised.

60 months

CaseWeightCore assumptionsImplied valueReturn / CAGR
Bear25%$13 EPS; 16x P/E; political intervention and normalized power prices cap returns$208-26.4% / -5.9%
Base50%$25 EPS; 22x P/E; contracted generation, synergies and buybacks compound per share$550+94.7% / +14.3%
Bull25%$38 EPS; 26x P/E; scarce reliable power earns sustained premiums and projects deliver$988+249.7% / +28.5%

Probability-weighted working value: approximately $574, or 15.2% annualised.

Catalysts

  • Calpine integration achieving operating, commercial and financing synergies without degrading reliability.
  • Crane restarting in 2027 on budget and beginning delivery under its long-term agreement.
  • Additional 15–20-year nuclear or portfolio PPAs with creditworthy customers at attractive risk-adjusted spreads.
  • Nuclear capacity factors returning above 94% with fewer non-refuelling outage days.
  • License extensions, uprates and interconnection reuse increasing output from existing sites.
  • Asset-sale proceeds, free cash flow and repurchases reducing leverage and share count.
  • Higher forward capacity and power prices being captured through disciplined hedging rather than speculative exposure.

Risks

  • Nuclear operations: unplanned outages, safety events, NRC action and long-duration maintenance can remove high-margin output.
  • Calpine integration: the transaction increases debt, commodity exposure, asset diversity and execution complexity.
  • Regulatory and political intervention: rate caps, market redesign, co-location rules or windfall measures could reduce scarcity economics.
  • Commodity and hedge risk: realized results can differ materially from market curves and GAAP derivative marks.
  • Project risk: Crane restart, uprates and life extensions can be delayed or exceed budget.
  • Customer concentration: large-load PPAs may concentrate credit, delivery and reputational exposure.
  • Environmental liabilities: nuclear decommissioning, spent fuel, gas emissions and legacy sites require long-duration capital.
  • Factor concentration: CEG increases PowerFund exposure to AI-related electricity demand rather than offsetting it.

Invalidation

Warning — investigate and freeze additions

  • Owned nuclear capacity factor falls below 91% for two quarters outside planned refuelling schedules.
  • Calpine synergy or 2026/2027 adjusted EPS expectations fall by more than 10%.
  • Net leverage does not decline on the planned path after required divestitures and integration spending.
  • Crane's expected restart slips beyond 2028 or remaining cost rises materially.
  • Forward valuation exceeds approximately 27x normalized EPS without equivalent growth in contracted cash flow.

Reduce — normally trim 25–50%

  • Adjusted EPS guidance is reduced by more than 15%, excluding a clearly reversible mark-to-market item.
  • A material nuclear unit experiences a multi-quarter unplanned outage or adverse NRC status.
  • Calpine integration produces recurring availability, control or liquidity problems.
  • Political or market-rule changes impair the economics of multiple existing plants or major PPAs.
  • Counterparty, collateral or hedge requirements consume materially more liquidity than forecast.

Invalidate — exit unless a documented exception is approved

  • A serious nuclear safety or regulatory event permanently impairs a major site or the fleet's operating licence.
  • Constellation cannot maintain investment-grade credit while funding integration and growth commitments.
  • Long-term contracts fail to earn an acceptable return after fuel, capacity, collateral and operating risk.
  • Structural market reform prevents the fleet from monetizing reliable generation across its principal regions.
  • Accounting, controls or commodity-risk evidence makes adjusted earnings an unreliable measure of cash economics.

Competitive notes

Constellation's moat is physical and regulatory: nuclear licences, scarce interconnections, operating expertise, customer origination and a large dispatchable fleet cannot be recreated quickly. Calpine adds geographic and fuel diversity plus retail and commercial capabilities.

Competitors include Vistra, NRG, Talen, regulated utilities and new renewable/storage developers. Buyers of large blocks of power retain negotiating leverage, and governments ultimately design the markets. Competitive advantage must be measured through availability, realized margin, contract quality and return on invested capital—not generation megawatts alone.

Next diligence

  1. Build a pro-forma Calpine bridge covering debt, synergies, maintenance capital, tax attributes and per-share accretion.
  2. Track each nuclear site's capacity factor, outage days, NRC status, licence life and major capital programme.
  3. Catalogue PPAs by counterparty, MW, term, start date, escalation, delivery obligation and credit support.
  4. Model merchant exposure and hedge coverage by region and year; distinguish GAAP marks from realized cash economics.
  5. Maintain a Crane restart budget, milestone and contingency schedule.
  6. Treat CEG as an AI-power factor holding in portfolio stress tests, not as a full diversifier.

Next scheduled review: Q3 2026 results; earlier following a Crane, NRC, Calpine or major market-rule update.